N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine

C71H77N17O7S3 — CID 159295188

IUPACN-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine
SMILESCOc1cc(S(C)(=O)=O)ccc1-c1c(C)sc2cnc(Nc3cnn(C4CCCCC4)c3)nc12.COc1cc(S(C)(=O)=O)ccc1-c1cccc2cnc(Nc3cnn(C4CCNCC4)c3)nc12.COc1ccccc1-c1cncc2cnc(Nc3cnn(C4CCCCC4)c3)nc12
InChIInChI=1S/C24H26N6O3S.C24H27N5O3S2.C23H24N6O/c1-33-22-12-19(34(2,31)32)6-7-20(22)21-5-3-4-16-13-26-24(29-23(16)21)28-17-14-27-30(15-17)18-8-10-25-11-9-18;1-15-22(19-10-9-18(34(3,30)31)11-20(19)32-2)23-21(33-15)13-25-24(28-23)27-16-12-26-29(14-16)17-7-5-4-6-8-17;1-30-21-10-6-5-9-19(21)20-14-24-11-16-12-25-23(28-22(16)20)27-17-13-26-29(15-17)18-7-3-2-4-8-18/h3-7,12-15,18,25H,8-11H2,1-2H3,(H,26,28,29);9-14,17H,4-8H2,1-3H3,(H,25,27,28);5-6,9-15,18H,2-4,7-8H2,1H3,(H,25,27,28)
InChIKeyLAPWVWQXKUUFGK-UHFFFAOYSA-N
MW1376.71 g/mol
LogP14.24
Rot. Bonds17

About N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine

N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine (PubChem CID 159295188) has the molecular formula C71H77N17O7S3 and a molecular weight of 1376.71 g/mol. Its IUPAC name is N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine.

Molecular Properties

Compound NameN-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine
PubChem CID159295188
Molecular FormulaC71H77N17O7S3
Molecular Weight1376.71 g/mol
Exact Mass1375.54
IUPAC NameN-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine
SMILESCOc1cc(S(C)(=O)=O)ccc1-c1c(C)sc2cnc(Nc3cnn(C4CCCCC4)c3)nc12.COc1cc(S(C)(=O)=O)ccc1-c1cccc2cnc(Nc3cnn(C4CCNCC4)c3)nc12.COc1ccccc1-c1cncc2cnc(Nc3cnn(C4CCCCC4)c3)nc12
InChIInChI=1S/C24H26N6O3S.C24H27N5O3S2.C23H24N6O/c1-33-22-12-19(34(2,31)32)6-7-20(22)21-5-3-4-16-13-26-24(29-23(16)21)28-17-14-27-30(15-17)18-8-10-25-11-9-18;1-15-22(19-10-9-18(34(3,30)31)11-20(19)32-2)23-21(33-15)13-25-24(28-23)27-16-12-26-29(14-16)17-7-5-4-6-8-17;1-30-21-10-6-5-9-19(21)20-14-24-11-16-12-25-23(28-22(16)20)27-17-13-26-29(15-17)18-7-3-2-4-8-18/h3-7,12-15,18,25H,8-11H2,1-2H3,(H,26,28,29);9-14,17H,4-8H2,1-3H3,(H,25,27,28);5-6,9-15,18H,2-4,7-8H2,1H3,(H,25,27,28)
InChIKeyLAPWVWQXKUUFGK-UHFFFAOYSA-N
XLogP14.24
TPSA287.78 Ų
H-Bond Donors4
H-Bond Acceptors25
Rotatable Bonds17
Heavy Atoms98
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001376.71
LogP ≤ 514.24
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1025

Analyze N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine?
The IUPAC name of N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine (CID 159295188) is N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine.
What is the SMILES notation for N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine?
The canonical SMILES for N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine is COc1cc(S(C)(=O)=O)ccc1-c1c(C)sc2cnc(Nc3cnn(C4CCCCC4)c3)nc12.COc1cc(S(C)(=O)=O)ccc1-c1cccc2cnc(Nc3cnn(C4CCNCC4)c3)nc12.COc1ccccc1-c1cncc2cnc(Nc3cnn(C4CCCCC4)c3)nc12.
What is the InChIKey of N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine?
The InChIKey is LAPWVWQXKUUFGK-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H26N6O3S.C24H27N5O3S2.C23H24N6O/c1-33-22-12-19(34(2,31)32)6-7-20(22)21-5-3-4-16-13-26-24(29-23(16)21)28-17-14-27-30(15-17)18-8-10-25-11-9-18;1-15-22(19-10-9-18(34(3,30)31)11-20(19)32-2)23-21(33-15)13-25-24(28-23)27-16-12-26-29(14-16)17-7-5-4-6-8-17;1-30-21-10-6-5-9-19(21)20-14-24-11-16-12-25-23(28-22(16)20)27-17-13-26-29(15-17)18-7-3-2-4-8-18/h3-7,12-15,18,25H,8-11H2,1-2H3,(H,26,28,29);9-14,17H,4-8H2,1-3H3,(H,25,27,28);5-6,9-15,18H,2-4,7-8H2,1H3,(H,25,27,28).
What are the key properties of N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine?
N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine has a molecular weight of 1376.71 g/mol, XLogP of 14.24, 17 rotatable bonds, 4 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-cyclohexylpyrazol-4-yl)-7-(2-methoxy-4-methylsulfonylphenyl)-6-methylthieno[3,2-d]pyrimidin-2-amine;N-(1-cyclohexylpyrazol-4-yl)-8-(2-methoxyphenyl)pyrido[4,3-d]pyrimidin-2-amine;8-(2-methoxy-4-methylsulfonylphenyl)-N-(1-piperidin-4-ylpyrazol-4-yl)quinazolin-2-amine is sourced from PubChem (CID 159295188), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).